enfortumab,Pembrolizumab,cisplatin,carboplatin,gemcitabine
Astellas,Merck,Seagen
['urothelial carcinoma', 'urothelial', 'enfortumab', 'pembro', ' vedo']
enfortumab vedotin/pembrolizumab combo shows safety, efficacy in metastatic urothelial carcinoma #urology #urologist #asco23 
The Leading News Source for Urologists - https://t.co/hDKngB4IyE
Expert clinical analysis. Practice advice. Policy perspectives.